Buyout bigs back $11bn orthopedic deal

Blackstone, Goldman Sachs, KKR and TPG have agreed to take private Biomet, a maker of replacement joints, alongside the company’s founder. At the same time, Biomet is investigating stock option back-dating practices approved by senior management.